H-Index
10
Scimago Lab
powered by Scopus
eISSN: 2325-4416
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo

MSMbanner
AmJCaseRep

Annals
ISI-Home

Expression of TP53, BCL-2, and VEGFA Genes in Esophagus Carcinoma and its Biological Significance

Wei Wei, Yanqin Wang, Xiaoming Yu, Lan Ye, Yuhua Jiang, Yufeng Cheng

Cancer Center, The Second Hospital of Shandong University, Jinan, Shandong, China (mainland)

Med Sci Monit 2015; 21:3016-3022

DOI: 10.12659/MSM.894640

Available online:

Published: 2015-10-06


BACKGROUND: The pathogenesis of esophagus carcinoma involves a cascade process consisting of multiple factors and accumulation of gene mutations. It is known that vascular endothelial growth factor (VEGF) mainly regulates de novo vascular formation while B-cell lymphoma-2 (BCL-2) gene exerts a tumor-suppressing effect. The prominent expression of VEGFA and BCL-2 genes, along with the most famous tumor-suppressor gene, TP53, raise the possibly of gene interaction. This study therefore investigated the effect and correlation of TP53, BCL-2, and VEGFA genes on cell proliferation and apoptosis of esophagus carcinoma.
MATERIAL AND METHODS: A total of 30 male rats were prepared by subcutaneous injection of methyl-benzyl-nitrosamine (MBNA) to induce esophagus cancer, along with 30 controlled rats which received saline instead. After 4, 10, 20, or 30 weeks, rats were sacrificed to observe the morphological changes of esophageal mucosa. Cell apoptosis was quantified by terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling (TUNEL) assay. Immunohistochemical (IHC) staining was employed to examine the expression of TP53, BCL-2 and VEGFA genes.
RESULTS: With the progression of cancer, pathological damages of esophageal tissue aggravated while the cancer cell apoptosis gradually decreased compared to controlled animals. Protein levels of p53, Bcl-2, and VEGF in the model group were significantly elevated at each time point. Positive correlations existed between p53 and Bcl-2 or VEGF.
CONCLUSIONS: Abnormally elevated expression of TP53, BCL-2, and VEGFA genes may participate in the proliferation of esophagus cancer cells in a synergistic manner.

Keywords: Barrett Esophagus - metabolism, Apoptosis, Animals, Carcinoma - metabolism, Cell Proliferation, Dimethylnitrosamine - analogs & derivatives, Esophageal Neoplasms - metabolism, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, In Situ Nick-End Labeling, Proto-Oncogene Proteins c-bcl-2 - metabolism, Proto-Oncogene Proteins c-bcl-6 - metabolism, Rats, Rats, Wistar, Tumor Suppressor Protein p53 - metabolism, Vascular Endothelial Growth Factor A - metabolism



Back